Stocks · Korea
007570
KOSPI
Ilyang Pharmaceutical
An overview for this page is not available in English yet. The figures below are updated daily.
Key figures 2026-10-07 basis
PER21.60x
PBR0.63x
EPS375 KRW
BPS12,934 KRW
ROE7.89%
Dividend yield1.91%
DPS155 KRW
Payout ratio41.33%
Returns and 52-week range
1W+0.00%
1M-3.11%
3M-2.76%
6M-27.55%
1Y-44.52%
YTD-44.52%
52W high16,240원
52W low7,290원
From 52W high-50.12%
Financial results (consolidated)
| Period | Revenue | Operating income | Net income | OP margin |
|---|---|---|---|---|
| 2022 | 2,478억 | 142억 | 198억 | 5.8% |
| 2023 | 2,667억 | 164억 | -20억 | 6.1% |
| 2024 | 2,689억 | 110억 | 105억 | 4.1% |
| 2025 | 2,724억 | 50억 | 71억 | 1.8% |
| Quarterly | ||||
| 2024 4Q | 85억 | -43,354,879원 | 22억 | -0.5% |
| 2025 1Q | 620억 | 34억 | 38억 | 5.5% |
| 2025 2Q | 627억 | 12억 | 6억 | 1.9% |
| 2025 3Q | 688억 | -2억 | 84억 | -0.2% |
| 2025 4Q | 789억 | 6억 | -56억 | 0.7% |
| 2026 1Q | 651억 | -74억 | 170억 | -11.3% |
Company
Address: 경기도 용인시 기흥구 하갈로 110
Peers in the same sector
Recent filings
- 2026-08-14반기보고서 (2026.06)
- 2026-05-15분기보고서 (2026.03)
- 2026-03-18사업보고서 (2025.12)
- 2025-11-13분기보고서 (2025.09)
- 2025-08-18주요사항보고서(자기주식취득신탁계약해지결정) Major
- 2025-08-14반기보고서 (2025.06)
- 2025-05-15분기보고서 (2025.03)
Source: DART (Financial Supervisory Service electronic disclosure)
Sources and notes
This page summarizes public filings, market data and news for information only. It is not a recommendation to buy or sell any security. Figures are as of the dates shown; check the original filings before making decisions.